Dimensional Fund Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16M | Sell |
1,650,950
-55,251
| -3% | -$206K | ﹤0.01% | 2461 |
|
|
2025
Q1 | $4.71M | Buy |
1,706,201
+403,269
| +31% | +$1.11M | ﹤0.01% | 2510 |
|
|
2024
Q4 | $7.22M | Buy |
1,302,932
+673,570
| +107% | +$3.73M | ﹤0.01% | 2425 |
|
|
2024
Q3 | $5.25M | Buy |
629,362
+257,470
| +69% | +$2.15M | ﹤0.01% | 2510 |
|
|
2024
Q2 | $2.53M | Buy |
371,892
+31,875
| +9% | +$217K | ﹤0.01% | 2709 |
|
|
2024
Q1 | $2.23M | Buy |
340,017
+262,192
| +337% | +$1.72M | ﹤0.01% | 2768 |
|
|
2023
Q4 | $506K | Sell |
77,825
-10,887
| -12% | -$70.7K | ﹤0.01% | 3042 |
|
|
2023
Q3 | $446K | Sell |
88,712
-149,652
| -63% | -$752K | ﹤0.01% | 3065 |
|
|
2023
Q2 | $2.09M | Buy |
238,364
+1,253
| +0.5% | +$11K | ﹤0.01% | 2774 |
|
|
2023
Q1 | $2.81M | Buy |
237,111
+138,171
| +140% | +$1.64M | ﹤0.01% | 2651 |
|
|
2022
Q4 | $1.01K | Buy |
98,940
+65,628
| +197% | +$667 | ﹤0.01% | 2896 |
|
|
2022
Q3 | $196K | Buy |
+33,312
| New | +$196K | ﹤0.01% | 3241 |
|